Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.
about
Monoclonal antibody form and function: manufacturing the right antibodies for treating drug abusePlant-produced candidate countermeasures against emerging and reemerging infections and bioterror agentsThe mucosal immune system: From dentistry to vaccine developmentThe Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis BWhen plant virology met Agrobacterium: the rise of the deconstructed clonesPurification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.An efficient Foxtail mosaic virus vector system with reduced environmental riskExpression and immunogenicity of the mycobacterial Ag85B/ESAT-6 antigens produced in transgenic plants by elastin-like peptide fusion strategy.Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Plant-derived human butyrylcholinesterase, but not an organophosphorous-compound hydrolyzing variant thereof, protects rodents against nerve agentsPlague in Guinea pigs and its prevention by subunit vaccinesHumoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.Smallpox subunit vaccine produced in Planta confers protection in mice.Application of a Scalable Plant Transient Gene Expression Platform for Malaria Vaccine Development.Plant-derived vaccines: a look back at the highlights and a view to the challenges on the road ahead.Plants as a source of butyrylcholinesterase variants designed for enhanced cocaine hydrolase activity.Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.Chloroplast-derived anthrax and other vaccine antigens: their immunogenic and immunoprotective properties.Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.FGL chaperone-assembled fimbrial polyadhesins: anti-immune armament of Gram-negative bacterial pathogens.Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and functionExpression of verocytotoxic Escherichia coli antigens in tobacco seeds and evaluation of gut immunity after oral administration in mouse model.Recent progress in the development of plant derived vaccines.Design of virus-based nanomaterials for medicine, biotechnology, and energy.An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles.Plant-made vaccine antigens and biopharmaceuticals.Adhesive organelles of Gram-negative pathogens assembled with the classical chaperone/usher machinery: structure and function from a clinical standpoint.Transient expression systems for plant-derived biopharmaceuticals.Novel transgenic rice-based vaccines.Current status of viral expression systems in plants and perspectives for oral vaccines development.Plague Vaccines: Status and Future.Heterologous protein production in plant systems.Plant-made pharmaceuticals: from 'Edible Vaccines' to Ebola therapeutics.Construction and screening of attenuated ΔphoP/Q Salmonella typhimurium vectored plague vaccine candidates.Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system.A Plant-Based Transient Expression System for the Rapid Production of Malaria Vaccine Candidates.Hydroponic Treatment of Nicotiana benthamiana with Kifunensine Modifies the N-glycans of Recombinant Glycoprotein Antigens to Predominantly Man9 High-Mannose Type upon Transient Overexpression.Plant Virus Expression Vectors: A Powerhouse for Global Health.Cyanophycinase CphE from P. alcaligenes produced in different compartments of N. benthamiana degrades high amounts of cyanophycin in plant extracts.Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco.
P2860
Q24632128-3117182B-097A-476A-B046-181E918730C6Q26783107-34C5C700-DA68-4C8D-940E-4FE92E228559Q26783887-632430B8-EF37-4548-B194-6993DA08E947Q28073401-0E50DDAE-2F77-4207-90A0-3794A95668F2Q28083891-77050D27-C60D-4617-AE68-D4A7AE8947CEQ33612949-D0C82882-5AA2-4DBD-BEDF-BB345833DE68Q33772857-2F141FD4-6E94-4F54-8426-104135D85831Q33794863-905C5C66-A633-4243-9039-3F1DB6F265DEQ34123275-96864A82-1ED8-484B-B368-7EFCD10A40E4Q34377206-744B31B2-748E-4B41-821A-8594085CDADCQ34805666-E59896A6-8B02-4B4C-ACAF-4B192F08B52CQ35153426-776A43FF-9B32-495D-924E-880F8AC1D9F7Q35800424-646AC563-3D34-4161-9081-00299285AC82Q36396520-1B74E5FB-B5F5-43E1-B4C3-31FAB674C584Q36445550-51B7605B-2AEE-4C72-A4DB-F27AB972EAD7Q36553288-B2749B36-50E6-4D76-9CA7-7456E2C69859Q36640081-910B90B5-8FF4-47C5-BC70-F1CCD81D577DQ36690295-F2C02090-1682-4637-9052-C961EF8876EDQ36804213-E8313C4F-9CF0-408A-A361-CDCBE7731869Q36852090-1B235EFB-9C6C-40E9-AFDD-F77B8D128E00Q37182165-36D269E8-A4DC-4DC5-9049-2D28A875AEE9Q37210135-387D3E32-DD6D-40C9-99F8-BE8C357F466AQ37290098-6948B320-9192-476A-98C7-DCC68C3B9CCDQ37346447-3A028FE1-7642-409A-A3DC-7A815D1B90C9Q37348115-EB98958C-3AC8-46E8-8642-2E9B52176A2AQ37616370-762EFF89-3512-44B3-B9AD-3607B354CC7FQ37673260-CF2779EC-7AA3-43ED-A12C-F0DDBB4CB512Q37776717-85AD016C-5116-4495-BF60-B091223AE1DDQ38229883-AE894CAF-6ACC-4EA8-84DC-8007C9734E4AQ38307990-ECB0D666-BD38-43D1-B881-C955842C2632Q38813137-0C373466-2D6C-4632-9A6F-6BA07F61E514Q38992414-474368B5-CE54-421B-ACCC-66D733AFDD20Q40140378-C1FEAD5B-E390-4C35-86FA-E62B429545E1Q41418787-04ABFE46-AFA8-4B02-92E9-4295E8A68BF2Q41439514-1D61A7B6-B1DC-4276-A6C2-4DB74838837EQ47955495-8A417687-25B0-43B1-9648-FA3543E9BD57Q49470037-BC88B03F-EAD0-438E-900C-7FBC5EC713CEQ50864889-28B2995A-42D6-4865-9028-0F4294F233F0Q51273213-73308EE1-4869-413B-B030-D96AA57D675DQ51593198-2A9C866F-E4FC-4E30-9AE5-48A68BD596D4
P2860
Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Protection conferred by recomb ...... lable plant expression system.
@ast
Protection conferred by recomb ...... lable plant expression system.
@en
Protection conferred by recomb ...... lable plant expression system.
@nl
type
label
Protection conferred by recomb ...... lable plant expression system.
@ast
Protection conferred by recomb ...... lable plant expression system.
@en
Protection conferred by recomb ...... lable plant expression system.
@nl
prefLabel
Protection conferred by recomb ...... lable plant expression system.
@ast
Protection conferred by recomb ...... lable plant expression system.
@en
Protection conferred by recomb ...... lable plant expression system.
@nl
P2093
P2860
P356
P1476
Protection conferred by recomb ...... lable plant expression system.
@en
P2093
Anatoli Giritch
Chad J Roy
Charles J Arntzen
Hugh S Mason
Luca Santi
Robert Webb
Sylvestre Marillonnet
Victor Klimyuk
Yuri Gleba
P2860
P304
P356
10.1073/PNAS.0510014103
P407
P577
2006-01-12T00:00:00Z